Your browser doesn't support javascript.
loading
The first Middle East and North Africa expert consensus recommendations for the management of advanced colorectal cancer.
Kourie, Hampig R; Ibnshamsah, Fahad; Zouein, Joseph; Naim, Nabih; Abbasi, Salah; Allahloubi, Nasr; Al-Naqqash, Manwar; Alolayan, Ashwaq; Alshehri, Ahmed; Bitar, Nizar; Bounedjar, Adda; Farsi, Abdulaziz Al; Shamsi, Humaid El; Ghali, Ramy; Jaafar, Hassan; Larbaoui, Blaha; Mahrous, Mervat; Mrabti, Hind; Nweir, Abdul Razzak; Oukkal, Mohamed; Rasul, Kakil; Razavi, Mohsen; Turfa, Rim; Khatib, Sami; Shamseddine, Ali.
Afiliação
  • Kourie HR; Department of Hematology-Oncology, Faculty of Medicine, Saint Joseph University of Beirut.
  • Ibnshamsah F; Adult Medical Oncology King Fahad Specialist Hospital Dammam, KSA.
  • Zouein J; Department of Hematology-Oncology, Faculty of Medicine, Saint Joseph University of Beirut.
  • Naim N; Department of Hematology-Oncology, Faculty of Medicine, Saint Joseph University of Beirut.
  • Abbasi S; Al-Khalidi Medical Center, Jordan.
  • Allahloubi N; National Cancer Institute, Cairo University, Egypt.
  • Al-Naqqash M; College of Medicine, University of Baghdad, Iraq.
  • Alolayan A; The National Guard Hospital, Riyadh, KSA.
  • Alshehri A; King Abdulaziz Medical City, Jeddah, KSA.
  • Bitar N; Sahel General Hospital, Lebanon.
  • Bounedjar A; Faculty of Medicine, University of Blida 1, Algeria.
  • Farsi AA; Royal Hospital, Muscat, Oman.
  • Shamsi HE; Department of Oncology, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
  • Ghali R; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Jaafar H; Department of Clinical Oncology, Ain Shams University, Egypt.
  • Larbaoui B; SKSH, UAE.
  • Mahrous M; Department of Medical Oncology Anti cancer center 'Emir Abdel Kader' Oran, Algeria.
  • Mrabti H; Prince Sultan Military Medical City, Riyadh, KSA.
  • Nweir AR; Institut National d'oncologie, Mohamed V University, Rabat, Morocco.
  • Oukkal M; Hama National Hospital, Ministry of Health, Syria.
  • Rasul K; Department of Medical Oncology, Beni Messous University Hospital, Algiers, Algeria.
  • Razavi M; NCCCR, Qatar.
  • Turfa R; Iran University of Medical Sciences, Iran.
  • Khatib S; King Hussein Cancer Center KHCC, Jordan.
  • Shamseddine A; Al Khaldi Hospital, Jordan.
Future Oncol ; 18(24): 2733-2744, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35791837
ABSTRACT
Colorectal cancer (CRC) is ranked as the third most prevalent and the second deadliest cancer worldwide. In the Middle East and North Africa (MENA) region, the number of CRC cases increased over the past decades and will nearly double by 2030. The lack of clear MENA guidelines for the management of patients with CRC represents a step backwards in the fight against this burden. Therefore a panel of 24 MENA experts in the field of gastrointestinal oncology developed, using a Delphi process, the first consensus recommendations for the management of patients with advanced CRC. Forty-seven different statements were formulated in the areas of epidemiology, screening, biomarkers and treatment. These recommendations will guide, standardize and unify the management of this cancer in the MENA region.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans País como assunto: Africa / Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans País como assunto: Africa / Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article